FOLH1 and metastatic neoplasm: Perera et al. [9] evaluated the diagnostic accuracy of 68Ga-PSMA-11 PET/CT for the detection of metastatic disease in both primary (high-risk and advanced prostate cancer) and secondary staging (at BCR) (Figure 1).